(CNN) – The vacancies against covid-19 are not recommended, as indicated on Saturday by the Public Health England, the Dra. Mary Ramsay, however, states that the governing body is updating this week to decide that the exchange of vacancies against covid-19 was a “reasonable” option.
«Geen recomendamos mezclar las vacunas contra el covid-19; if its first dose is the Pfizer vaccine, it should not receive the AstraZeneca vaccine for its second dose and vice versa », Ramsay said in a statement.
“You can have extremely rare occasions when the vaccine is not available, or when the patient is receiving the vaccine. It is necessary to do everything possible to give the vaccine vaccine, but when it is not possible, it is better to have a second dose of another vaccine that is not administered, ”he said.
Ramsay clarified the position of the United Kingdom on the issue of vacancies after an update of the Government’s vacancy strategy manual on 31 December.
What did the guide update? The guide of the juveniles details that if the vaccine is not available, or if the first product is received, “it is reasonable to offer a dose of the product available locally to complete the program”.
“If this option is preferred, it is likely that the person will run a high-risk or consider it likely that he will assist again,” he said.
What do you use in the United Kingdom? The United Kingdom authorizes the emergence of the Pfizer / BioNTech vaccine on December 2 and the Oxford / AstraZeneca vaccine on December 30.
The guide recommends that both vacancies be administered in doses, with a minimum of 21 diffraction slides for Pfizer / BioNTech and 28 diffraction slides for AstraZeneca, with protection by a large proportion of space in the second inoculation.
The pains of the United Kingdom contradict EE.UU’s. The updated guide from the United Kingdom contradicts the United States’ requirements for the vacancies authorized by Pfizer / BioNTech and Modern. The Centers for the Control and Prevention of Injuries (CDC) have announced that the vacancies against covid-19 are authorized “no interchangeable son between them or other products of the vaccine against covid-19”, and that “security and efficiency of a series of mixed products has not been evaluated. Both doses of the deben series complete with the same product ”.
The CDC agrees, without embarrassment, that “it is inadvertently administering doses of different products of the ARNm covid-19 vaccine, no additional dose of any of the products is currently recommended”.